scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.11277 |
P698 | PubMed publication ID | 14558081 |
P2093 | author name string | Stephen A Paget | |
Yusuf Yazici | |||
Doruk Erkan | |||
P433 | issue | 10 | |
P304 | page(s) | 2769-2772 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Arthritis and Rheumatism | Q23929027 |
P1476 | title | Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events | |
P478 | volume | 48 |
Q24817087 | Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score |
Q35165677 | Are rheumatologists' treatment decisions influenced by patients' age? |
Q35555217 | Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities. |
Q46598057 | Pharmaceutical care of patients with rheumatoid and psoriatic arthritis receiving etanercept |
Q37807149 | Surveillance for and Prevention of Nonrheumatologic Diseases in the Patient with a Rheumatologic Diagnosis |
Search more.